Results
3
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
3 companies
Orchid Pharma
Market Cap: ₹38.3b
A pharmaceutical company, engages in the development, manufacture, and marketing of active pharmaceutical ingredients, bulk actives, finished dosage formulations, and nutraceuticals in India.
ORCHPHARMA
₹756.05
7D
6.9%
1Y
-33.9%
Solara Active Pharma Sciences
Market Cap: ₹30.7b
Manufactures, produces, processes, formulates, sells, imports, exports, merchandises, distributes, trades in, and deals in active pharmaceutical ingredients (API) in India, Asia Pacific, Europe, North America, South America, and internationally.
SOLARA
₹636.80
7D
3.1%
1Y
9.7%
Strides Pharma Science
Market Cap: ₹81.6b
Develops, manufactures, and sells pharmaceutical products in Africa, Australia, North America, Europe, Asia, India, and internationally.
STAR
₹885.25
7D
-1.5%
1Y
-5.5%